The CDC recommends that pregnant women including with HIV-infection and confirmed, probable, or suspected influenza A (H1N1) are at risk of potentially serious disease due to influenza viruses and need to receive antiviral therapy with Oseltamivir (Tamiflu).
Archives for Medical Prescription
Influenza Antiviral Medication Dosing
Below is a table consist of influenza antiviral medication dosing either Oseltamivir and Zanamivir for Influenza Treatment and Chemoprophylaxis. The table describe the dosing of oseltamivir and zanamivir since Influenza A (H1N1) viruses are sensitive to those medications rather than amantadine and ramantadine.
The Safety of Oseltamivir and Zanamivir for the Treatment and Prevention of Influenza
What you will find in this article are sections discuss about the cause of seasonal influenza, the use of oseltamivir and zanamivir for the treatment of uncomplicated influenza as FDA approval, safety profile of oseltamivir and zanamivir (prophylaxis in adults, treatment in adults and children) including report table of safety outcomes for oral oseltamivir and zanamivir used for treatment and prophylaxis.
The Clinical Use of Pamidronate in a Variety of Diseases
Sections you will find in this article are sections discuss about Pharmacology of Pamidronate, Clinical Uses (Hypercalcaemia of Malignancy, Paget’s Disease, Osteolytic Bone Metastases and Multiple Myeloma, Osteoporosis), The most common side effects of pamidronate, The Recommendation in Using Pamidronate, and anticipated use and financial implications.
